.jpg?format=webp&width=780)
The study aimed to evaluate the usefulness of single gene non-invasive prenatal screening (NIPS-SGD) in a high-risk reproductive genetics clinic. The NIPS-SGD panel assessed pathogenic variants in 30 genes for pregnant individuals with indications such as advanced sperm age, nuchal translucency, fetal anomaly, or family history of a condition covered by the panel. Out of 253 individuals who underwent NIPS-SGD, 8 (3.5%) tested positive, and 5 cases had altered medical management. However, NIPS-SGD should not replace clinically indicated diagnostic testing. There is a possibility of incidental findings, such as parental diagnoses and misattributed parentage.
Like
Save
Share